Glenmark & IADVL Release Special Cover in collabroation with Indian Postal Service

The initiative aims to raise awareness and combat stigma associated with the skin pigmentation disorder (vitiligo).
The special cover features the winning artwork from a painting competition of dermatologists from across the country, organized by Glenmark on World Vitiligo Day.

Mumbai, India, August 26, 2023: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company, has joined forces with The Indian Association of Dermatologists, Venereologists, and Leprologists (IADVL) to unveil a special cover aimed at raising awareness and support for individuals living with vitiligo, a skin disorder that affects pigmentation.

In an effort to combat misinformation and promote acceptance, Glenmark and IADVL conducted a unique painting competition named “Power of Paint and Brush” on World Vitiligo Day, June 25, 2023. The competition aimed to spotlight the significance of awareness, understanding, and treatment for vitiligo patients. Dermatologists from across the country participated, submitting over 100 entries that creatively portrayed the journey of patients with vitiligo and advocated for the importance of embracing diversity.

Dr. Naushin Ara from Jaipur SMS Medical College crafted the winning painting, titled “Colour of Thoughts.” The winning artwork has been transformed into a captivating special cover that will serve as a constant reminder of the significance of empathy, acceptance, and respect for those affected by vitiligo.

Addressing to the media persons on the occasion, Alok Malik, President and Business Head, India Formulations, Glenmark Pharmaceuticals Ltd. said, “This initiative echoes Glenmark’s core commitment to inclusivity and positive influence. Beyond medicines, we believe in shaping a better society through collaborations that enhance awareness and well-being of the patients. This initiative underscores our steadfast dedication to fostering empathy and harmony, reaffirming our pledge to create a meaningful difference in the lives of people with vitiligo in the country.”

Dr Vijay Zawar, President, IADVL said, “We believe in the power of collective efforts to create awareness and acceptance. This special cover is a small but impactful step towards supporting vitiligo patients and promoting a more inclusive society.”

A panel of judges, including Mr. Uday Parker, a Gold Medalist from JJ School of Arts, and key representatives from IADVL, meticulously reviewed the submissions to select the winning piece.

About vitiligo: Vitiligo is a condition characterized by the loss of skin pigmentation due to the malfunction or destruction of melanin-producing cells, and impacts not only physical appearance but also psychological well-being. Despite its prevalence and impact, vitiligo often remains misunderstood, leading to societal stigmatization and prejudice. India is home to the highest rate of vitiligo cases globally, with one in ten individuals being affected by the condition.

About Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd. (BSE: 532296 | NSE: GLENMARK) is an integrated, research‐led, global pharmaceutical company, with a presence across Branded, Generics, and OTC segments; with a focus on therapeutic areas of respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents, and operations in over 80 countries. In Vivo/Scrip 100 positions Glenmark amongst the Top 100 Companies Ranked by R&D and Pharmaceutical Sales, 2021; while Generics Bulletin/In Vivo places it in the Top 50 Generics and Biosimilars Companies Ranked by Sales, 2021. The company has also been Great Place To Work® Certified™ in India. Glenmark’s Green House Gas (GHG) emission reduction targets have been approved in 2023 by the Science Based Target initiative (SBTi), becoming the second Indian Pharmaceuticals company to achieve this approval. The organization has impacted over 2.9 million lives over the last decade through its CSR interventions. For more information, visit www.glenmarkpharma.com. You can follow us on LinkedIn (Glenmark Pharmaceuticals) and Instagram (glenmark_pharma).

About IADVL: The Indian Association of Dermatologists, Venereologists and Leprologists (IADVL), the largest representing official society of Indian Dermatologists was established in its present form on 28th January, 1973. IADVL also happens to be the world’s 2nd largest Association of Dermatologists behind the American Academy of Dermatology. It is the national association of Indian medical specialists who manage patients with skin disorders, sexually transmitted infections (STIs) or leprosy. The current member strength of the association is 16,000 members.ends GNI